Evidence brief · printable

Multiple Myeloma evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Multiple Myeloma: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/plasma-cell-myeloma.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Dexamethasone 15 trials
  • Bortezomib 8 trials
  • LENALIDOMIDE 8 trials
  • Carfilzomib 4 trials
  • Cyclophosphamide 4 trials
  • Cyclosporine 4 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Acupuncture and related techniques 9 trials · 6 completed · 5 with results
  • Massage, osteopathy and manual therapy 6 trials · 4 completed · 3 with results
  • Education, coaching and self-management 22 trials · 15 completed · 2 with results
  • Care coordination, navigation and outreach 4 trials · 3 completed · 1 with results
  • Dietary patterns and specific diets 10 trials · 2 completed · 1 with results
  • Cognitive behavioural and related therapies 2 trials · 2 completed · 1 with results

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Testing the Investigational Medication Combination of Daratumumab and Teclistamab… NCT06948084
  • ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for… NCT07106710
  • Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or… NCT06465316
  • Compassionate Communication and Advance Care Planning to Improve End of Life Care… NCT05444348
  • HEME Home Transfusion Program NCT06487247
  • DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in… NCT06296368

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 26 trials of supplements and nutraceuticals found, none measured mood, anxiety and wellbeing 19 trials of other approaches did
  • Among 21 trials of oxygen, light, temperature and manual therapies found, none measured mood, anxiety and wellbeing 19 trials of other approaches did
  • Among 26 trials of supplements and nutraceuticals found, none measured physical function and exercise capacity 16 trials of other approaches did
  • Supplements and nutraceuticals: feasibility, adherence and safety 7 trials, no results posted yet
  • Exercise and physical activity: quality of life 5 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (162 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.